158 related articles for article (PubMed ID: 1437791)
1. [Inflammatory changes in the gastric mucosa of patients with idiopathic non-ulcer dyspepsia and the effect of colloid bismuth treatment on the course of inflammation].
Muszyński J; Biernacka D; Stepka M; Galczak A; Zalewski L; Ehrmann A
Pol Tyg Lek; 1992 Jan 20-27; 47(3-4):79-83. PubMed ID: 1437791
[TBL] [Abstract][Full Text] [Related]
2. [Effect of colloid bismuth treatment on Campylobacter pylori infection of the gastric mucosa and the clinical course of non-ulcer dyspepsia].
Muszyński J; Biernacka D; Bogacka-Zatorska E; Stepka M; Galczak A; Zalewski L; Lissowska K; Ehrmann A
Pol Tyg Lek; 1992 Jan 20-27; 47(3-4):75-8. PubMed ID: 1437790
[TBL] [Abstract][Full Text] [Related]
3. Is there any relationship between functional dyspepsia and chronic gastritis associated with Helicobacter pylori infection?
Kyzekové J; Arlt J; Arltová M
Hepatogastroenterology; 2001; 48(38):594-602. PubMed ID: 11379362
[TBL] [Abstract][Full Text] [Related]
4. Colloidal bismuth subcitrate in non-ulcer dyspepsia.
Khanna MU; Abraham P; Nair NG; Mistry FP; Vora IM
J Postgrad Med; 1992; 38(3):106-8. PubMed ID: 1303406
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia.
Koskenpato J; Färkkilä M; Sipponen P
Scand J Gastroenterol; 2002 Jul; 37(7):778-84. PubMed ID: 12190090
[TBL] [Abstract][Full Text] [Related]
6. [Effect of eradication treatment on histological changes of the gastric mucosa in patients with non-ulcer dyspesia and Helicobacter pylori infection. Randomized prospective study].
Kyzeková J
Vnitr Lek; 1999 Feb; 45(2):90-6. PubMed ID: 15641227
[TBL] [Abstract][Full Text] [Related]
7. Double blind trial of colloidal bismuth subcitrate versus placebo in Helicobacter pylori positive patients with non-ulcer dyspepsia.
Vaira D; Holton J; Ainley C; Falzon M; Osborn J; D'Anna L; Romanos A; Chandrakumaran K; McNeil I
Ital J Gastroenterol; 1992 Sep; 24(7):400-4. PubMed ID: 1392023
[TBL] [Abstract][Full Text] [Related]
8. [Morphologic changes in chronic active superficial Campylobacter pylori-positive antrum gastritis after treatment with bismuth].
Sorf M; Krislo V; Gogora M; Masek O
Vnitr Lek; 1990 Aug; 36(8):759-62. PubMed ID: 2136460
[TBL] [Abstract][Full Text] [Related]
9. Non-ulcer dyspepsia and Helicobacter pylori infection--morphological analysis according to the Sydney system--changes before and after treatment.
Lewy-Trenda I; Trenda P; Wierzchniewska A
Pol J Pathol; 1996; 47(2):57-63. PubMed ID: 8854727
[TBL] [Abstract][Full Text] [Related]
10. [Campylobacter pylori--relation to gastric pathology and the effect of bismuth therapy].
Huslarová A; Fric P; Jirásek A
Sb Lek; 1990; 92(11-12):349-53. PubMed ID: 2136429
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological assessment of gastric biopsy samples of patients with Helicobacter pylori infection--metronidazole resistance and compliance problems in the United Arab Emirates.
Adeyemi EO; Fadlalla H; al-Homsi M; Nnalue NA; Goodwin S; Boehme D; Sim AJ
Ital J Gastroenterol; 1992 Oct; 24(8):436-9. PubMed ID: 1421445
[TBL] [Abstract][Full Text] [Related]
12. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin and D cells in patients with gastritis in the course of Helicobacter pylori eradication: a six-month, follow-up study.
Milutinovic AS; Todorovic V; Milosavljevic T; Micev M; Spuran M; Drndarevic N
Eur J Gastroenterol Hepatol; 2003 Jul; 15(7):755-66. PubMed ID: 12811306
[TBL] [Abstract][Full Text] [Related]
14. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
[TBL] [Abstract][Full Text] [Related]
15. Non-ulcer dyspepsia and short term De-Nol therapy: a placebo controlled trial with particular reference to the role of Campylobacter pylori.
Rokkas T; Pursey C; Uzoechina E; Dorrington L; Simmons NA; Filipe MI; Sladen GE
Gut; 1988 Oct; 29(10):1386-91. PubMed ID: 3058555
[TBL] [Abstract][Full Text] [Related]
16. Campylobacter pylori in upper digestive tract diseases in children.
Celińska-Cedro D; Socha J; Teisseyre M
Mater Med Pol; 1989; 21(4):259-62. PubMed ID: 2489238
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
18. [Gastric mucosa lesions in gastric ulcer disease. Initial study and 1-year follow-up after Helicobacter pylori eradication].
Bermejo F; Boixeda D; Gisbert JP; Sanz JM; Defarges V; Alvarez Calatayud G; Martín de Argila C
Gastroenterol Hepatol; 2000; 23(6):269-74. PubMed ID: 15324621
[TBL] [Abstract][Full Text] [Related]
19. Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety.
Kuipers EJ; Uyterlinde AM; Peña AS; Hazenberg HJ; Bloemena E; Lindeman J; Klinkenberg-Knol EC; Meuwissen SG
Am J Gastroenterol; 1995 Sep; 90(9):1401-6. PubMed ID: 7661157
[TBL] [Abstract][Full Text] [Related]
20. [Chronic gastritis associated to Helicobacter pylori in patients with non-ulcerating dyspepsia and with duodenal ulcer].
Magalhães AF; Almeida JR; Guerrazzi F; Yamanaka A; Mesquita MA; Trevisan MA; Ulson CM
Rev Paul Med; 1991; 109(5):197-203. PubMed ID: 1821064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
